238th American Chemical Society National Meeting
238th American Chemical Society National Meeting
批准号:
7749286
负责人:
SHANA J STURLA
金额:
$1.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2010-06-30
关键词:
AmericanAnalytical ChemistryApplications GrantsAreaAwardBiologicalChemicalsChemistryCommunitiesComplexDNA AdductsDevelopmentDiseaseDistrict of ColumbiaEnsureEnvironmental HealthEtiologyFundingGoalsHealthHumanIndividualLinkMalignant NeoplasmsMass Spectrum AnalysisMedicineMonitorOrganic ChemistryPharmaceutical PreparationsPlatinumPostdoctoral FellowRequest for ApplicationsResearchRiskRisk AssessmentScientistSeriesSocietiesSolutionsSystemTherapeuticToxic effectToxicologyTravelUnited States National Institutes of HealthWorkbasecancer therapychemical carcinogenesisdrug discoverydrug metabolismgraduate studenthuman diseaseimprovedinnovationmeetingsmitochondrial dysfunctionnext generationnovel strategiesprogramspublic health relevancesafety testingsymposium
中文摘要
描述(由申请人提供):本资助申请要求资助一系列题为“化学毒理学新方面”的专题讨论会的部分支持。“这些专题讨论会是美国化学学会化学毒理学分部将于2009年8月16日至20日在华盛顿举行的第238届全国会议和学会博览会上提出的计划的一部分。这些专题讨论会将为介绍新的研究提供论坛,这些研究强调基于化学毒理学的现代科学方法和应用,包括(1)水生毒理学进展,重点是将机制和监测联系起来以改善风险评估,(2)安全性测试中的人类药物代谢,(3)药物诱导的线粒体功能障碍和人类疾病,(4)DNA加合物和人类健康,和(5)涉及铂基化疗药物的癌症治疗新方法。毒理学领域的化学研究最近已转向开发更新的策略,以更好地了解化学品与复杂的生物和环境系统相互作用的机制方面。将这一认识应用于人类健康问题的进展具有巨大的创新和巨大进步潜力。然而,该领域的广泛性带来的持续挑战集中在将所有专注于基于化学的解决方案但沉浸在不同生物医学领域的个人聚集在一起。因此,这次会议需要作为一个全国性的首要场所,把这个不同的化学家群体聚集在一起,一个备受尊敬的和不同的科学家群体已经同意提出他们的最新发现。
公共卫生相关性:计划中的专题讨论会与美国国立卫生研究院在环境卫生、癌症治疗和病因学、药物代谢和毒性以及普通医学领域的目标有关。更广泛的科学界也会发现所提供的信息与生物、医药和分析化学以及化学毒理学领域有关。将向研究生和博士后研究员提供旅行奖励,以确保下一代科学家了解药物发现,质谱,合成有机化学和化学致癌等领域的重要进展,以及他们如何协同工作以开发确定疾病病因和风险的新方法。
英文摘要
DESCRIPTION (provided by applicant): This grant application requests funding for partial support of a series of symposia with the title "New Facets of Chemical Toxicology." These symposia are part of the program to be presented by the American Chemical Society Division of Chemical Toxicology at the 238th National Meeting and Exposition of the Society in Washington, DC on August 16-20, 2009. These symposia will provide forums for the presentation of new research that emphasizes modern scientific approaches and applications based in chemical toxicology, including (1) Advances in Aquatic Toxicology, with emphasis on linking mechanism and monitoring to improve risk assessment, (2) Human Drug Metabolites in Safety Testing, (3) Drug-Induced Mitochondrial Dysfunction and Human Disease, (4) DNA Adducts and Human Health, and (5) New approaches for Cancer Therapy involving Platinum-based Chemotherapeutics. Chemistry research in the area of toxicology has recently shifted to the development of newer strategies for better understanding mechanistic aspects of interactions of chemicals with complex biological and environmental systems. Progress in applying this understanding to human health concerns has great potential for innovative and dramatic advances. However, a continued challenge imposed by the breadth of the field centers on bringing together individuals who are all focused on chemistry-based solutions, but immersed within diverse biomedical arenas. Thus, this meeting is needed as a premiere national venue to bring this diverse group of chemists together, and a highly respected and diverse group of scientists have agreed to present their newest findings.
Public Health Relevance: The planned symposia have relevance to the goals of the National Institutes of Health in the areas of environmental health, cancer therapeutics and etiology, drug metabolism and toxicity, and general medicine. The broader scientific community will also find the information presented relevant in the fields of biological, medicinal and analytical chemistry as well as chemical toxicology. Travel awards will be made to graduate students and postdoctoral fellows to ensure that the next generation of scientists is aware of the important advances in the fields of drug discovery, mass spectrometry, synthetic organic chemistry and chemical carcinogenesis to mention a few and how they work in concert to develop new ways to determine disease etiology and risk.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Covalent Modification of DNA and Protein by Bioactivated Antitumor Acylfulvenes
-
批准号:7259793
-
项目类别:
-
资助金额:$24.29万
-
财政年份:2007
-
负责人:SHANA J STURLA
-
依托单位:
Covalent Modification of DNA and Protein by Bioactivated Antitumor Acylfulvenes
-
批准号:7496683
-
项目类别:
-
资助金额:$2.81万
-
财政年份:2007
-
负责人:SHANA J STURLA
-
依托单位:
Covalent Modification of DNA and Protein by Bioactivated Antitumor Acylfulvenes
-
批准号:7611449
-
项目类别:
-
资助金额:$4.5万
-
财政年份:2007
-
负责人:SHANA J STURLA
-
依托单位:
Covalent Modification of DNA and Protein by Bioactivated Antitumor Acylfulvenes
-
批准号:7778843
-
项目类别:
-
资助金额:$18.36万
-
财政年份:2007
-
负责人:SHANA J STURLA
-
依托单位:
Covalent Modification of DNA and Protein by Bioactivated Antitumor Acylfulvenes
-
批准号:8101215
-
项目类别:
-
资助金额:$17.81万
-
财政年份:2007
-
负责人:SHANA J STURLA
-
依托单位:
Covalent Modification of DNA and Protein by Bioactivated Antitumor Acylfulvenes
-
批准号:7409710
-
项目类别:
-
资助金额:$29.42万
-
财政年份:2007
-
负责人:SHANA J STURLA
-
依托单位:
Covalent Modification of DNA and Protein by Bioactivated Antitumor Acylfulvenes
-
批准号:7612044
-
项目类别:
-
资助金额:$26.49万
-
财政年份:2007
-
负责人:SHANA J STURLA
-
依托单位:
Oxygen-linked Phenol-DNA Adducts
-
批准号:7110988
-
项目类别:
-
资助金额:$14.01万
-
财政年份:2004
-
负责人:SHANA J STURLA
-
依托单位:
Oxygen-linked Phenol-DNA Adducts
-
批准号:7477690
-
项目类别:
-
资助金额:$14.53万
-
财政年份:2004
-
负责人:SHANA J STURLA
-
依托单位:
Oxygen-linked Phenol-DNA Adducts
-
批准号:7274792
-
项目类别:
-
资助金额:$14.27万
-
财政年份:2004
-
负责人:SHANA J STURLA
-
依托单位:
Oxygen-linked Phenol-DNA Adducts
-
批准号:6931968
-
项目类别:
-
资助金额:$13.76万
-
财政年份:2004
-
负责人:SHANA J STURLA
-
依托单位:
Oxygen-linked Phenol-DNA Adducts
-
批准号:6807790
-
项目类别:
-
资助金额:$11.35万
-
财政年份:2004
-
负责人:SHANA J STURLA
-
依托单位:
Chemoprevention of Lung Cancer by myo Inositol Analogs
-
批准号:6442826
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2001
-
负责人:SHANA J STURLA
-
依托单位:
海外基金